There was no evidence of heterogeneity in the OR by family history (P = 0.66), or for any of the other tumor characteristics considered (PR status, HER2 status, axillary node status, size or morphology; P ≥ 0.074). The gene discussed is ERBB2; the disease is neoplasm.